Highmark Commercial Medical Policy - Pennsylvania |
Medical Policy: | L-27-016 |
Topic: | Organ or Disease Oriented Panels |
Section: | Laboratory |
Effective Date: | January 1, 2016 |
Issue Date: | January 4, 2016 |
Last Reviewed: | November 2015 |
Certain ranges of procedure codes represent organ or disease oriented panels. These panels combine certain laboratory tests under a specific problem-oriented classification. |
This policy is designed to address medical guidelines that are appropriate for the majority of individuals with a particular disease, illness, or condition. Each person's unique clinical circumstances may warrant individual consideration, based on review of applicable medical records.
Policy Position Coverage is subject to the specific terms of the member’s benefit plan. |
Procedure codes 80048-80090 represent organ or disease oriented panels. When performed for asymptomatic patients, organ or disease oriented panels are considered screening and are only covered by certain groups or programs as indicated in benefits.
Many of the disease-oriented panel tests on the table attachment are covered. The component tests for each covered panel are listed. These are the minimum tests that must be performed before a disease-oriented panel code can be reported.
If less than the minimum tests are performed, payment should be made for the individual tests.
See Medical Policy Bulletin L-29 for information regarding evocative/suppression testing panels. See attachment for information on organ or disease oriented panels. |
The policy position applies to all commercial lines of business |
FEP Guidelines |
This medical policy may not apply to FEP. Medical policy is not an authorization, certification, explanation of benefits or a contract. Benefits are determined by the Federal Employee Program. |
Denial Statements |
A network provider can bill the member for the non-covered service.
Links |